THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. (2020). Mediterranean Journal of Hematology and Infectious Diseases, 13(1), e2021013. https://doi.org/10.4084/mjhid.2021.013